The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification
Open accessAbstract
IMPORTANCE: Individuals can be classified as being at clinical high risk (CHR) for psychosis if they meet at least one of the ultra-high-risk (UHR) inclusion criteria (brief limited intermittent psychotic symptoms [BLIPS] and/or attenuated psychotic symptoms [APS] and/or genetic risk and deterioration syndrome [GRD]) and/or basic symptoms [BS]. The meta-analytical risk of psychosis of these different subgroups is still unknown. OBJECTIVE: To compare the risk of psychosis in CHR individuals who met at least one of the major inclusion criteria and in individuals not at CHR for psychosis (CHR-). DATA SOURCES: Electronic databases (Web of Science, MEDLINE, Scopus) were searched until June 18, 2015, along with investigation of citations of previous publications and a manual search of the reference lists of retrieved articles. STUDY SELECTION: We included original follow-up studies of CHR individuals who reported the risk of psychosis classified according to the presence of any BLIPS, APS and GRD, APS alone, GRD alone, BS, and CHR-. DATA EXTRACTION AND SYNTHESIS: Independent extraction by multiple observers and random-effects meta-analysis of proportions. Moderators were tested with meta-regression analyses (Bonferroni corrected). Heterogeneity was assessed with the I2 index. Sensitivity analyses tested robustness of results. Publication biases were assessed with funnel plots and the Egger test. MAIN OUTCOMES AND MEASURES: The proportion of each subgroup with any psychotic disorder at 6, 12, 24, 36, and 48 or more months of follow-up. RESULTS: Thirty-three independent studies comprising up to 4227 individuals were included. The meta-analytical proportion of individuals meeting each UHR subgroup at intake was: 0.85 APS (95%CI, 0.79-0.90), 0.1 BLIPS (95%CI, 0.06-0.14), and 0.05 GRD (95%CI, 0.03-0.07). There were no significant differences in psychosis risk at any time point between the APS and GRD and the APS-alone subgroups. There was a higher risk of psychosis in the any BLIPS greater than APS greater than GRD-alone subgroups at 24, 36, and 48 or more months of follow-up. There was no evidence that the GRD subgroup has a higher risk of psychosis than the CHR- subgroup. There were too few BS or BS and UHR studies to allow robust conclusions. CONCLUSIONS AND RELEVANCE: There is meta-analytical evidence that BLIPS represents separate risk subgroup compared with the APS. The GRD subgroup is infrequent and not associated with an increased risk of psychosis. Future studies are advised to stratify their findings across these different subgroups. The CHR guidelines should be updated to reflect these differences.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2009) · doi:10.1002/9780470743386 · Cited by 14,225
Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2021) · doi:10.1002/9781119558378 · Cited by 9,799
(2000) · Cited by 9,198
Transformations Related to the Angular and the Square Root
Freeman, M. F., & Tukey, J. W. (1950) · The Annals of Mathematical Statistics · doi:10.1214/aoms/1177729756 · Cited by 2,665
Cited by
Sorted by citations
Ten simple rules for conducting umbrella reviews
Fusar-Poli, P., & Radua, J. (2018) · Evidence Based Mental Health · doi:10.1136/ebmental-2018-300014 · Cited by 724
Self-citationImproving outcomes of first‐episode psychosis: an overview
Fusar‐Poli, P., McGorry, P. D., & Kane, J. M. (2017) · World Psychiatry · doi:10.1002/wps.20446 · Cited by 575
Self-citationWhat causes psychosis? An umbrella review of risk and protective factors
Radua, J., Ramella‐Cravaro, V., Ioannidis, J. P. A., Reichenberg, A., Phiphopthatsanee, N., Amir, T., Yenn Thoo, H., Oliver, D., Davies, C., Morgan, C., et al. (2018) · World Psychiatry · doi:10.1002/wps.20490 · Cited by 553
Self-citationPreventive psychiatry: a blueprint for improving the mental health of young people
Fusar‐Poli, P., Correll, C. U., Arango, C., Berk, M., Patel, V., & Ioannidis, J. P. A. (2021) · World Psychiatry · doi:10.1002/wps.20869 · Cited by 497
Self-citationPrevention of Psychosis: Advances in Detection, Prognosis, and Intervention
Fusar-Poli, P., Salazar de Pablo, G., Correll, C. U., Meyer-Lindenberg, A., Millan, M. J., Borgwardt, S., Galderisi, S., Bechdolf, A., Pfennig, A., Kessing, L. V., et al. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.4779 · Cited by 476
Self-citationSalazar de Pablo, G., Radua, J., Pereira, J., Bonoldi, I., Arienti, V., Besana, F., Soardo, L., Cabras, A., Fortea, L., Catalan, A., et al. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.0830 · Cited by 375
Self-citationWhat is good mental health? A scoping review
Fusar-Poli, P., Salazar de Pablo, G., De Micheli, A., Nieman, D. H., Correll, C. U., Kessing, L. V., Pfennig, A., Bechdolf, A., Borgwardt, S., Arango, C., et al. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.12.105 · Cited by 356
Self-citationFusar‐Poli, P., Tantardini, M., Simone, S. D., Ramella‐Cravaro, V., Oliver, D., Kingdon, J., Kotlicka‐Antczak, M., Valmaggia, L., Lee, J., Millan, M. J., et al. (2016) · European Psychiatry · doi:10.1016/j.eurpsy.2016.09.003 · Cited by 327
Self-citationA critique of the “ultra‐high risk” and “transition” paradigm
van Os, J., & Guloksuz, S. (2017) · World Psychiatry · doi:10.1002/wps.20423 · Cited by 261
Fusar-Poli, P., Rutigliano, G., Stahl, D., Davies, C., Bonoldi, I., Reilly, T., & McGuire, P. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.0284 · Cited by 246
Self-citationLack of evidence to favor specific preventive interventions in psychosis: a network meta‐analysis
Davies, C., Cipriani, A., Ioannidis, J. P. A., Radua, J., Stahl, D., Provenzani, U., McGuire, P., & Fusar‐Poli, P. (2018) · World Psychiatry · doi:10.1002/wps.20526 · Cited by 229
Self-citationde Pablo, G. S., Studerus, E., Vaquerizo‐Serrano, J., Irving, J., Catalán, A., Oliver, D., Baldwin, H., Danese, A., Fazel, S., Steyerberg, E. W., et al. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa120 · Cited by 234
Self-citationThe Clinical High-Risk State for Psychosis (CHR-P), Version II
Fusar‐Poli, P. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw158 · Cited by 219
Self-citationFusar-Poli, P. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00355 · Cited by 218
Self-citationDiagnostic Stability of ICD/DSM First Episode Psychosis Diagnoses: Meta-analysis
Fusar‐Poli, P., Cappucciati, M., Rutigliano, G., Heslin, M., Stahl, D. R., Brittenden, Z., Caverzasi, E., McGuire, P. K., & Carpenter, W. T. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw020 · Cited by 220
Self-citationThe Science of Prognosis in Psychiatry: A Review
Fusar-Poli, P., Hijazi, Z., Stahl, D., & Steyerberg, E. W. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.2530 · Cited by 197
Self-citationCatalán, A., de Pablo, G. S., Vaquerizo‐Serrano, J., Mosillo, P., Baldwin, H., Fernández‐Rivas, A., Moreno, C., Arango, C., Correll, C. U., Bonoldi, I., et al. (2020) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13322 · Cited by 176
Self-citationOliver, D., Reilly, T. J., Boy, O. B., Petros, N., Davies, C., Borgwardt, S., McGuire, P. K., & Fusar‐Poli, P. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz039 · Cited by 182
Self-citationPrognosis of Brief Psychotic Episodes: A Meta-analysis
Fusar-Poli, P., Cappucciati, M., Bonoldi, I., Hui, L. M. C., Rutigliano, G., Stahl, D. R., Borgwardt, S., Politi, P., Mishara, A. L., Lawrie, S. M., et al. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.2313 · Cited by 151
Self-citationRutigliano, G., Valmaggia, L., Landi, P., Frascarelli, M., Cappucciati, M., Sear, V., Rocchetti, M., De Micheli, A., Jones, C., Palombini, E., et al. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.05.053 · Cited by 138
Self-citationDuration of untreated illness as a key to early intervention in schizophrenia: a review.
Murru, A., & Carpiniello, B. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2016.10.003 · Cited by 135
Schmidt, A., Cappucciati, M., Raduà, J., Rutigliano, G., Rocchetti, M., Dell’Osso, L., Politi, P., Borgwardt, S., Reilly, T. J., Valmaggia, L., et al. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw098 · Cited by 131
Self-citationUher, R., Pavlová, B., Raduà, J., Provenzani, U., Najafi, S., Fortea, L., Ortuño, M., Nazarova, A., Perroud, N. A., Palaniyappan, L. K., et al. (2023) · World Psychiatry · doi:10.1002/wps.21147 · Cited by 143
Self-citationFusar-Poli, P., Rutigliano, G., Stahl, D., Davies, C., De Micheli, A., Ramella-Cravaro, V., Bonoldi, I., & McGuire, P. (2017) · European Psychiatry · doi:10.1016/j.eurpsy.2016.11.010 · Cited by 120
Self-citationFusar‐Poli, P., Cappucciati, M., Micheli, A. D., Rutigliano, G., Bonoldi, I., Tognin, S., Ramella‐Cravaro, V., Castagnini, A. C., & McGuire, P. K. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw151 · Cited by 118
Self-citationCannabidiol as a potential treatment for psychosis
Davies, C., & Bhattacharyya, S. (2019) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125319881916 · Cited by 121
Preventive Treatments for Psychosis: Umbrella Review (Just the Evidence)
Fusar-Poli, P., Davies, C., Solmi, M., Brondino, N., De Micheli, A., Kotlicka-Antczak, M., Shin, J. I., & Radua, J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00764 · Cited by 108
Self-citationDavies, C., Radua, J., Cipriani, A., Stahl, D., Provenzani, U., McGuire, P., & Fusar-Poli, P. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00187 · Cited by 107
Self-citationImmune-inflammatory markers and psychosis risk: A systematic review and meta-analysis
Misiak, B., Bartoli, F., Carrà, G., Stańczykiewicz, B., Gładka, A., Frydecka, D., Samochowiec, J., Jarosz, K., Hadryś, T., & Miller, B. J. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105200 · Cited by 107
Salazar de Pablo, G., Catalan, A., & Fusar-Poli, P. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.3561 · Cited by 103
Self-citationFusar-Poli, P., Werbeloff, N., Rutigliano, G., Oliver, D., Davies, C., Stahl, D., McGuire, P., & Osborn, D. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sby070 · Cited by 95
Self-citationJiang, Y., Wang, J., Zhou, E., Palaniyappan, L. K., Luo, C., Ji, G., Yang, J., Wang, Y., Zhang, Y., Huang, C., et al. (2023) · Nature Mental Health · doi:10.1038/s44220-023-00024-0 · Cited by 103
Solmi, M., Soardo, L., Kaur, S., Azis, M., Cabras, A., Censori, M., Fausti, L., Besana, F., de Pablo, G. S., & Fusar‐Poli, P. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02029-8 · Cited by 107
Self-citationEEG microstates as biomarker for psychosis in ultra-high-risk patients
de Bock, R., Mackintosh, A., Maier, F., Borgwardt, S., Riecher‐Rössler, A., & Andreou, C. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00963-7 · Cited by 96
Self-citationFusar-Poli, P., Sullivan, S. A., Shah, J. L., & Uhlhaas, P. J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00774 · Cited by 92
Self-citationKotlicka‐Antczak, M., Podgórski, M. T., Oliver, D., Marić, N. P., Valmaggia, L., & Fusar‐Poli, P. (2020) · Early Intervention in Psychiatry · doi:10.1111/eip.12950 · Cited by 93
Self-citationStuderus, E., Ramyead, A., & Riecher‐Rössler, A. (2017) · Psychological Medicine · doi:10.1017/s0033291716003494 · Cited by 95
Self-citationAn overview of medical risk factors for childhood psychosis: Implications for research and treatment
Giannitelli, M., Consoli, A., Raffin, M., Jardri, R., Levinson, D. F., Cohen, D., & Laurent‐Levinson, C. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.05.011 · Cited by 88
de Pablo, G. S., Soardo, L., Cabras, A., Pereira, J., Kaur, S., Besana, F., Arienti, V., Coronelli, F., Shin, J. I., Solmi, M., et al. (2022) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796021000639 · Cited by 85
Self-citationNatural Language Processing markers in first episode psychosis and people at clinical high-risk
Morgan, S. E., Diederen, K. M. J., Vértes, P. E., Ip, S., Wang, B., Thompson, B., Demjaha, A., Micheli, A. D., Oliver, D., Liakata, M., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01722-y · Cited by 86
Self-citationEstablishing a clinical service to prevent psychosis: What, how and when? Systematic review
de Pablo, G. S., Estradé, A., Cutroni, M., Andlauer, O., & Fusar‐Poli, P. (2021) · Translational Psychiatry · doi:10.1038/s41398-020-01165-x · Cited by 87
Self-citationSanfelici, R., Dwyer, D. B., Antonucci, L. A., & Koutsouleris, N. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.02.009 · Cited by 82
Takahashi, T., & Suzuki, M. (2018) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12670 · Cited by 85
Dysregulated Lipid Metabolism Precedes Onset of Psychosis
Dickens, A. M., Sen, P., Kempton, M. J., Barrantes‐Vidal, N., Iyegbe, C. O., Nordentoft, M., Pollak, T. A., Riecher‐Rössler, A., Ruhrmann, S., Sachs, G., et al. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.07.012 · Cited by 79
Self-citationClinical trajectories in the ultra-high risk for psychosis population
Polari, A. R., Lavoie, S., Yuen, H. P., Amminger, G. P., Berger, G. E., Chen, E. Y. H., de Haan, L., Hartmann, J., Markulev, C., Melville, F., et al. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.01.022 · Cited by 82
Self-citationNarrative identity in the psychosis spectrum: A systematic review and developmental model
Cowan, H. R., Mittal, V. A., & McAdams, D. P. (2021) · Clinical Psychology Review · doi:10.1016/j.cpr.2021.102067 · Cited by 82
Allen, P., Azis, M., Modinos, G., Bossong, M. G., Bonoldi, I., Samson, C., Quinn, B., Kempton, M. J., Howes, O. D., Stone, J. M., et al. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx169 · Cited by 82
Self-citationTognin, S., van Hell, H. H., Merritt, K., Rossum, I. W.-V., Bossong, M. G., Kempton, M. J., Modinos, G., Fusar‐Poli, P., Mechelli, A., Dazzan, P., et al. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz067 · Cited by 82
Self-citationAtypical processing of uncertainty in individuals at risk for psychosis
Cole, D. M., Diaconescu, A. O., Pfeiffer, U. J., Brodersen, K. H., Mathys, C. D., Julkowski, D., Ruhrmann, S., Schilbach, L., Tittgemeyer, M., Vogeley, K. T., et al. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102239 · Cited by 72
Evaluating the Hypothesis That Schizophrenia Is an Inflammatory Disorder
Miller, B. J., & Goldsmith, D. R. (2020) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20200015 · Cited by 73
de Pablo, G. S., Guinart, D., Armendariz, A., Aymerich, C., Catalán, A., Alameda, L., Rogdaki, M., Baringo, E. M., Soler-Vidal, J., Oliver, D., et al. (2024) · Schizophrenia bulletin · doi:10.1093/schbul/sbae017 · Cited by 71
Self-citationSydnor, V. J., & Roalf, D. R. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.06.028 · Cited by 68
Oliver, D., Raduà, J., Reichenberg, A., Uher, R., & Fusar‐Poli, P. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00174 · Cited by 69
Self-citationInflammatory biomarkers in schizophrenia: Implications for heterogeneity and neurobiology
Miller, B. J., & Goldsmith, D. R. (2019) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2019.100006 · Cited by 72
What Is an Attenuated Psychotic Symptom? On the Importance of the Context
Fusar‐Poli, P., Raballo, A., & Parnas, J. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw182 · Cited by 67
Self-citationLabad, J. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.11.028 · Cited by 67
Self-citationLower speech connectedness linked to incidence of psychosis in people at clinical high risk
Spencer, T. J., Thompson, B., Oliver, D., Diederen, K. M. J., Demjaha, A., Weinstein, S., Morgan, S. E., Day, F., Valmaggia, L., Rutigliano, G., et al. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.09.002 · Cited by 66
Self-citationSchultze‐Lutter, F., Michel, C., Ruhrmann, S., & SCHIMMELMANN, B. G. (2017) · Psychological Medicine · doi:10.1017/s0033291717002586 · Cited by 69
Clinical high risk for psychosis in children and adolescents: a systematic review
Tor, J., Dolz, M., Sintes, A., Muñoz, D., Pardo, M., de la Serna, E., Puig, O., Sugranyes, G., & Baeza, I. (2017) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-017-1046-3 · Cited by 65
Inflammatory biomarkers in individuals at clinical high risk for psychosis (CHR-P): State or trait?
Khoury, R., & Nasrallah, H. A. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.04.017 · Cited by 65
Woods, S. W., Walsh, B. C., Powers, A. R., & McGlashan, T. H. (2019) · Springer eBooks · doi:10.1007/978-3-030-17336-4_5 · Cited by 65
Self-citationVerbal learning and hippocampal dysfunction in schizophrenia: A meta-analysis
Antoniades, M., Schoeler, T., Raduà, J., Valli, I., Allen, P., Kempton, M. J., & McGuire, P. K. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.12.001 · Cited by 70
Self-citationCarrión, R. E., Correll, C. U., Auther, A. M., & Cornblatt, B. A. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw155 · Cited by 63
Lee, T. Y., Lee, J., Kim, M., Choe, E., & Kwon, J. S. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx173 · Cited by 62
Self-citationKoren, D., Tzivoni, Y., Schalit, L., Adres, M., Reznik, N., Apter, A. S., & Parnas, J. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.12.022 · Cited by 64
Obsessive-compulsive symptoms in schizophrenia: an up-to-date review of literature
Tezenas du Montcel, C., Pelissolo, A., Schürhoff, F., & Pignon, B. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1051-y · Cited by 61
Fusar-Poli, P., Spencer, T., De Micheli, A., Curzi, V., Nandha, S., & McGuire, P. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.08.002 · Cited by 57
Self-citationMoritz, S., Gawęda, Ł., Heinz, A., & Gallinat, J. (2019) · Psychological Medicine · doi:10.1017/s0033291719001740 · Cited by 63
Semistructured Interview for Bipolar At Risk States (SIBARS)
Fusar‐Poli, P., Micheli, A. D., Rocchetti, M., Cappucciati, M., Ramella‐Cravaro, V., Rutigliano, G., Bonoldi, I., McGuire, P. K., & Falkenberg, I. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.03.074 · Cited by 60
Self-citationRaballo, A., Poletti, M., Preti, A., & McGorry, P. D. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.03.063 · Cited by 57
Self-citationClark, S. R., Baune, B. T., Schubert, K. O., Lavoie, S., Smesny, S., Rice, S., Schäfer, M. R., Benninger, F., Feucht, M., Klier, C. M., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.170 · Cited by 58
Self-citationSun, M., Wang, D., Jing, L., Xi, C., Dai, L., & Zhou, L. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.06.003 · Cited by 58
Tang, Y., Wang, J., Zhang, T., Xu, L. N., Qian, Z., Cui, H., Tang, X. Y., Whitfield‐Gabrieli, S., Whitfield, S., Shenton, M. E., et al. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.02.014 · Cited by 57
de Pablo, G. S., Besana, F., Arienti, V., Catalán, A., Vaquerizo‐Serrano, J., Cabras, A., Pereira, J. F., Soardo, L., Coronelli, F., Kaur, S., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100909 · Cited by 57
Self-citationSchultze‐Lutter, F., Nenadić, I., & Grant, P. S. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00476 · Cited by 57
Zheng, Y., Xu, T., Zhu, Y., Li, C., Wang, J., Livingstone, S., & Zhang, T. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbab044 · Cited by 60
Boldrini, T., Tanzilli, A., Pontillo, M., Chirumbolo, A., Vicari, S., & Lingiardi, V. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00429 · Cited by 57
Prediction of conversion to psychosis in individuals with an at-risk mental state
Riecher‐Rössler, A., & Studerus, E. (2017) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000320 · Cited by 61
Self-citationValue of schizophrenia treatment I: The patient journey
Mohr, P., Galderisi, S., Boyer, P., Wasserman, D., Arteel, P., Ieven, A., Kärkkäinen, H., Pereira, E., Guldemond, N., Winkler, P., et al. (2018) · European Psychiatry · doi:10.1016/j.eurpsy.2018.06.007 · Cited by 58
Oliver, D., Kotlicka-Antczak, M., Minichino, A., Spada, G., McGuire, P., & Fusar-Poli, P. (2018) · European Psychiatry · doi:10.1016/j.eurpsy.2017.10.001 · Cited by 51
Self-citationWalter, A., Suenderhauf, C., Harrisberger, F., Lenz, C., Smieskova, R., Chung, Y., Cannon, T. D., Bearden, C. E., Rapp, C., Bendfeldt, K., et al. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.10.007 · Cited by 56
Self-citationNeurocognitive dysfunction in subjects at clinical high risk for psychosis: A meta-analysis
Zheng, W., Zhang, Q.-E., Cai, D.-B., Ng, C. H., Ungvari, G. S., Ning, Y.-P., & Xiang, Y. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.05.001 · Cited by 51
Woods, S. W., Parker, S., Kerr, M., Walsh, B. C., Wijtenburg, S. A., Prunier, N., Núñez, Á., Buccilli, K., Mourgues, C., Brummitt, K., et al. (2023) · Early Intervention in Psychiatry · doi:10.1111/eip.13457 · Cited by 62
Self-citationThe Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo.
McHugh, M., McGorry, P., Yuen, H. P., Hickie, I., Thompson, A., de Haan, L., Mossaheb, N., Smesny, S., Lin, A., Markulev, C., et al. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.09.003 · Cited by 46
Self-citationJiang, Y., Luo, C., Wang, J., Palaniyappan, L. K., Chang, X., Xiang, S., Zhang, J., Duan, M., Huang, H., Gaser, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50267-3 · Cited by 59
Forty years of structural imaging in psychosis: promises and truth
Fusar‐Poli, P., & Meyer‐Lindenberg, A. (2016) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12619 · Cited by 57
Self-citationOliver, D., Arribas, M., Radua, J., Salazar de Pablo, G., De Micheli, A., Spada, G., Mensi, M. M., Kotlicka-Antczak, M., Borgatti, R., Solmi, M., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01611-w · Cited by 49
Self-citationFusar‐Poli, P., Palombini, E., Davies, C., Oliver, D., Bonoldi, I., Ramella‐Cravaro, V., & McGuire, P. K. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.06.015 · Cited by 51
Self-citationvan der Gaag, M., van den Berg, D. P. G., & Ising, H. K. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.08.018 · Cited by 48
DeLuca, J. S., Andorko, N. D., Chibani, D., Jay, S. Y., Rouhakhtar, P. R., Petti, E., Klaunig, M. J., Thompson, E. C., Millman, Z. B., Connors, K. M., et al. (2020) · Journal of Psychotherapy Integration · doi:10.1037/int0000211 · Cited by 46
Poletti, M., Pelizza, L., Azzali, S., Paterlini, F., Garlassi, S., Scazza, I., Chiri, L. R., Gebhardt, E., Pupo, S., & Andrea, R. (2018) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-018-1262-5 · Cited by 50
Do the Trajectories of Bipolar Disorder and Schizophrenia Follow a Universal Staging Model?
Duffy, A., Malhi, G. S., & Grof, P. (2017) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716649189 · Cited by 46
Fusar‐Poli, P., Micheli, A. D., Signorini, L., Baldwin, H., de Pablo, G. S., & McGuire, P. K. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100578 · Cited by 47
Self-citationFusar‐Poli, P. (2017) · World Psychiatry · doi:10.1002/wps.20405 · Cited by 45
Self-citationWorthington, M., & Cannon, T. D. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.770774 · Cited by 47
Leuci, E., Quattrone, E., Pellegrini, P., & Pelizza, L. (2019) · Early Intervention in Psychiatry · doi:10.1111/eip.12897 · Cited by 42
Biase, M. A. D., Karayumak, S. C., Lyall, A. E., Zalesky, A., Cho, K. I. K., Zhang, F., Kubicki, M. R., Yogesh Rathi, A., Lyons, M., Sylvain Bouix, A., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01128-8 · Cited by 43
Self-citationFryer, S. L., Roach, B. J., Ford, J. M., Donaldson, K. R., Calhoun, V. D., Pearlson, G. D., Kiehl, K. A., Srihari, V. H., McGlashan, T. H., Woods, S. W., et al. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx198 · Cited by 40
Self-citationNeuroanatomical heterogeneity and homogeneity in individuals at clinical high risk for psychosis
Baldwin, H., Raduà, J., Antoniades, M., Haas, S. S., Frangou, S., Agartz, I., Allen, P., Andreassen, O. A., Atkinson, K., Bachman, P., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02057-y · Cited by 43
Self-citationPelizza, L., Poletti, M., Azzali, S., Paterlini, F., Garlassi, S., Scazza, I., Chiri, L. R., Pupo, S., & Raballo, A. (2019) · Suicide and Life-Threatening Behavior · doi:10.1111/sltb.12549 · Cited by 42
Metadata
- Authors
- Fusar-Poli, P., Cappucciati, M., Borgwardt, S., Woods, S. W., Addington, J., Nelson, B., Nieman, D. H., Stahl, D. R., Rutigliano, G., Riecher-Rössler, A., Simon, A. E., Mizuno, M., Lee, T. Y., Kwon, J. S., Lam, M. M. L., Perez, J., Keri, S., Amminger, P., Metzler, S., Kawohl, W., Rössler, W., Lee, J., Labad, J., Ziermans, T., An, S. K., Liu, C.-C., Woodberry, K. A., Braham, A., Corcoran, C., McGorry, P., Yung, A. R., & McGuire, P. K.
- Affiliations
- Institute of Psychiatry, Psychology, and Neuroscience, King’s College, London, United Kingdom2OASIS Clinic, South London and Maudsley National Health Service Foundation Trust, London, United Kingdom
- King's College London (GB)
- University of Basel (CH)
- Yale University (US)
- University of Calgary (CA)
- The University of Melbourne (AU)
- Amsterdam UMC Location University of Amsterdam (NL)
- University of Basel Psychiatric Clinics, Basel, Switzerland
- Toho University (JP)
- Seoul National University (KR)
- Kwai Chung Hospital (CN)
- Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom
- Nyiro Gyula Hospital, National Institute of Psychiatry and Addictions, Budapest, Hungary
- Orygen, the National Centre of Excellence in Youth Mental Health, and Centre for Youth Mental Health, the University of Melbourne, Parkville, Australia
- University Hospital Zurich (CH)
- Centre for Social Psychiatry, Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Psychiatry Zurich, Zurich, Switzerland
- Institute of Mental Health (SG)
- Corporació Sanitària Parc Taulí (ES)
- Leiden University (NL)
- Yonsei University (KR)
- National Taiwan University (TW)
- Beth Israel Deaconess Medical Center (US)
- Hôpital Farhat Hached (TN)
- Columbia University (US)
- University of Manchester (GB)
- ORCID
- Cappucciati, Marco
- Borgwardt, Stefan
- Woods, Scott W.
- Addington, Jean
- Nelson, Barnaby
- Nieman, Dorien H.
- Stahl, Daniel R.
- Rutigliano, Grazia
- Simon, Andor E.
- Lee, Tae Young
- Kwon, Jun Soo
- Kawohl, Wolfram
- Lee, Jimmy
- Labad, Javier
- Ziermans, Tim
- An, Suk Kyoon
- Liu, Chen-Chung
- Woodberry, Kristen A.
- Braham, Amel
- Corcoran, Cheryl
- McGorry, Patrick
- Yung, Alison R.
- McGuire, Philip K.
- Venue
- JAMA Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2016-02-01
- Volume
- 73
- Issue
- 2
- Pages
- 113
- ISSN
- 2168-622X (ISSN-L)
- OpenAlex
- W2207056170
- Cited by
- 440
- References
- 65
- Citations by year
- 2026: 22 · 2025: 32 · 2024: 27 · 2023: 36 · 2022: 36 · 2021: 59 · 2020: 66 · 2019: 70 · 2018: 36 · 2017: 31 · 2016: 23
- FWCI
- 24.33
- Type
- journal article
- Language
- en
- Open access
- green
- pure.amsterdamumc.nl
- Licence
- other-oa
- Locations
- JAMA Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Own your potential (DEAKIN) (submittedVersion)
- edoc (University of Basel) (submittedVersion)
- Figshare (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Funders
- National Institute of Mental Health (K23MH066279, U01MH066160, R03MH108933)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Clinical Psychology › Psychopathy, Forensic Psychiatry, Sexual Offending
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Keywords
- clinical high risk for psychosis, attenuated psychotic symptoms, basic symptoms, transition to psychosis, bipolar disorder, psychosis spectrum disorders
- MeSH terms
- Humans, Psychotic Disorders, Risk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
